Mineralys Therapeutics
MLYS
#5635
Rank
C$1.99 B
Marketcap
C$22.53
Share price
-2.23%
Change (1 day)
-65.87%
Change (1 year)

Mineralys Therapeutics (MLYS) - Total debt

Total debt on the balance sheet as of June 2026 : N/A

According to Mineralys Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

Mineralys Therapeutics - Total debt on balance sheet (in 2020)

Total debt by year

Year Total debt Change
2020-12-31C$5.73 M